Short-lived medical isotopes and their generators are typically produced in nuclear reactors and cyclotrons that require extensive facilities.However,considering the environmental concerns and economic costs of these ...Short-lived medical isotopes and their generators are typically produced in nuclear reactors and cyclotrons that require extensive facilities.However,considering the environmental concerns and economic costs of these traditional approaches,modern laser technology,which provides extremely strong electric fields within tabletop-sized areas,can serve as a potential supplementary method.Focusing specifically on the(γ,p)generation of the vital medical isotopes^(47)Sc and^(67)Cu,we used both experimental results and PIC-GEANT4 simulations to demonstrate that laser-induced photonuclear reaction is a promising method for isotope production.We developed a model capable of calculating isotope yields under various laser conditions and acceleration mechanisms.The findings revealed that a 200 TW laser can sufficiently produce diagnostic amounts of^(47)Sc and^(67)Cu,while simultaneously providing high specific activity,which is significant in medical applications for improving treatment efficacy,enhancing image resolution,and reducing side effects.展开更多
The utilization of a proton beam from the China Spallation Neutron Source(CSNS)for producing medical radioisotopes is appealing owing to its high current intensity and high energy.The medical isotope production based ...The utilization of a proton beam from the China Spallation Neutron Source(CSNS)for producing medical radioisotopes is appealing owing to its high current intensity and high energy.The medical isotope production based on the proton beam at the CSNS is significant for the development of future radiopharmaceuticals,particularly for theα-emitting radiopharmaceu-ticals.The production yield and activity of typical medical isotopes were estimated using the FLUKA simulation.The results indicate that the 300-MeV proton beam with a power of 100 kW at CSNS-II is highly suitable for proof-of-principle studies of most medical radioisotopes.In particular,this proton beam offers tremendous advantages for the large-scale production of alpha radioisotopes,such as 225Ac,whose theoretical production yield can reach approximately 57 Ci/week.Based on these results,we provide perspectives on the use of CSNS proton beams to produce radioisotopes for medical applications.展开更多
文摘Short-lived medical isotopes and their generators are typically produced in nuclear reactors and cyclotrons that require extensive facilities.However,considering the environmental concerns and economic costs of these traditional approaches,modern laser technology,which provides extremely strong electric fields within tabletop-sized areas,can serve as a potential supplementary method.Focusing specifically on the(γ,p)generation of the vital medical isotopes^(47)Sc and^(67)Cu,we used both experimental results and PIC-GEANT4 simulations to demonstrate that laser-induced photonuclear reaction is a promising method for isotope production.We developed a model capable of calculating isotope yields under various laser conditions and acceleration mechanisms.The findings revealed that a 200 TW laser can sufficiently produce diagnostic amounts of^(47)Sc and^(67)Cu,while simultaneously providing high specific activity,which is significant in medical applications for improving treatment efficacy,enhancing image resolution,and reducing side effects.
基金the National Natural Science Foundation of China(No.12075135)the China Postdoctoral Science Foundation(No.2022M721908).
文摘The utilization of a proton beam from the China Spallation Neutron Source(CSNS)for producing medical radioisotopes is appealing owing to its high current intensity and high energy.The medical isotope production based on the proton beam at the CSNS is significant for the development of future radiopharmaceuticals,particularly for theα-emitting radiopharmaceu-ticals.The production yield and activity of typical medical isotopes were estimated using the FLUKA simulation.The results indicate that the 300-MeV proton beam with a power of 100 kW at CSNS-II is highly suitable for proof-of-principle studies of most medical radioisotopes.In particular,this proton beam offers tremendous advantages for the large-scale production of alpha radioisotopes,such as 225Ac,whose theoretical production yield can reach approximately 57 Ci/week.Based on these results,we provide perspectives on the use of CSNS proton beams to produce radioisotopes for medical applications.
